Literature DB >> 10024576

The levels and bactericidal capacity of antibodies directed against the UspA1 and UspA2 outer membrane proteins of Moraxella (Branhamella) catarrhalis in adults and children.

D Chen1, V Barniak, K R VanDerMeid, J C McMichael.   

Abstract

The UspA1 and UspA2 proteins from Moraxella catarrhalis share antigenic epitopes and are promising vaccine candidates. In this study, the levels and bactericidal activities of antibodies in sera from healthy adults and children toward UspA1 and UspA2 from the O35E strain were measured. Human sera contained antibodies to both proteins, and the levels of immunoglobulin G (IgG) antibodies were age dependent. Adult sera had significantly higher titers of IgG than child sera (P < 0.01). The IgG3 titers to the UspA proteins were higher than the IgG1 titers in the adults' sera, while the IgG1 titers were higher than the IgG3 titers in the children's sera (P < 0.05). The IgG antibodies in the sera from 2-month-old children appeared to be maternally derived, since the mean titer was significantly higher than that in sera from 6- to 7-month-old children (P < 0.05). Serum IgA antibodies to both UspA1 and UspA2 were low during the first 7 months of age but thereafter gradually increased along with the IgG titers. Analysis of sera absorbed with UspA1 or UspA2 showed that the antibodies to UspA1 and UspA2 were cross-reactive with each other and associated with serum bactericidal activity. Examination of affinity-purified human antibodies confirmed that naturally acquired antibodies to UspA1 and UspA2 were bactericidal and cross-reactive. These results support using UspA1 and UspA2 in a vaccine to prevent M. catarrhalis infections.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10024576      PMCID: PMC96462     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  Respiratory tract infections due to Branhamella catarrhalis: epidemiological data from Western Australia.

Authors:  C DiGiovanni; T V Riley; G F Hoyne; R Yeo; P Cooksey
Journal:  Epidemiol Infect       Date:  1987-10       Impact factor: 2.451

2.  Acute maxillary sinusitis in children.

Authors:  E R Wald; G J Milmoe; A Bowen; J Ledesma-Medina; N Salamon; C D Bluestone
Journal:  N Engl J Med       Date:  1981-03-26       Impact factor: 91.245

3.  Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study.

Authors:  D W Teele; J O Klein; B Rosner
Journal:  J Infect Dis       Date:  1989-07       Impact factor: 5.226

Review 4.  Branhamella catarrhalis: an organism gaining respect as a pathogen.

Authors:  B W Catlin
Journal:  Clin Microbiol Rev       Date:  1990-10       Impact factor: 26.132

5.  Respiratory tract carrier rates of Moraxella (Branhamella) catarrhalis in adults and children and interpretation of the isolation of M. catarrhalis from sputum.

Authors:  M Vaneechoutte; G Verschraegen; G Claeys; B Weise; A M Van den Abeele
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

6.  Branhamella catarrhalis: antigenic determinants and the development of the IgG subclass response in childhood.

Authors:  D Goldblatt; M W Turner; R J Levinsky
Journal:  J Infect Dis       Date:  1990-11       Impact factor: 5.226

7.  Branhamella catarrhalis in children and adults. A study of prevalence, time of colonisation, and association with upper and lower respiratory tract infections.

Authors:  T Ejlertsen; E Thisted; F Ebbesen; B Olesen; J Renneberg
Journal:  J Infect       Date:  1994-07       Impact factor: 6.072

8.  Otitis media and sinusitis in children. Role of Branhamella catarrhalis.

Authors:  C D Bluestone
Journal:  Drugs       Date:  1986       Impact factor: 9.546

9.  Treatment of acute maxillary sinusitis in childhood: a comparative study of amoxicillin and cefaclor.

Authors:  E R Wald; J S Reilly; M Casselbrant; J Ledesma-Medina; G J Milmoe; C D Bluestone; D Chiponis
Journal:  J Pediatr       Date:  1984-02       Impact factor: 4.406

10.  Branhamella (Moraxella) catarrhalis: pathogenic significance in respiratory infections.

Authors:  F M Boyle; P R Georghiou; M H Tilse; J G McCormack
Journal:  Med J Aust       Date:  1991-05-06       Impact factor: 7.738

View more
  26 in total

1.  Trimeric autotransporters of Haemophilus parasuis: generation of an extensive passenger domain repertoire specific for pathogenic strains.

Authors:  Sonia Pina; Alex Olvera; Anna Barceló; Albert Bensaid
Journal:  J Bacteriol       Date:  2008-11-14       Impact factor: 3.490

2.  Antigenic specificity of the mucosal antibody response to Moraxella catarrhalis in chronic obstructive pulmonary disease.

Authors:  Timothy F Murphy; Aimee L Brauer; Christoph Aebi; Sanjay Sethi
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

Review 3.  Potential impact of a Moraxella catarrhalis vaccine in COPD.

Authors:  Antonia C Perez; Timothy F Murphy
Journal:  Vaccine       Date:  2017-02-06       Impact factor: 3.641

4.  Bactericidal monoclonal antibody against Moraxella catarrhalis lipooligosaccharide cross-reacts with Haemophilus Spp.

Authors:  Raina T Gergova; Ianko D Iankov; Iana H Haralambieva; Ivan G Mitov
Journal:  Curr Microbiol       Date:  2007-01-05       Impact factor: 2.188

5.  Expression of the Moraxella catarrhalis UspA1 protein undergoes phase variation and is regulated at the transcriptional level.

Authors:  E R Lafontaine; N J Wagner; E J Hansen
Journal:  J Bacteriol       Date:  2001-03       Impact factor: 3.490

6.  Use of the chinchilla model for nasopharyngeal colonization to study gene expression by Moraxella catarrhalis.

Authors:  Todd C Hoopman; Wei Liu; Stephanie N Joslin; Christine Pybus; Jennifer L Sedillo; Maria Labandeira-Rey; Cassie A Laurence; Wei Wang; James A Richardson; Lauren O Bakaletz; Eric J Hansen
Journal:  Infect Immun       Date:  2011-12-19       Impact factor: 3.441

7.  The Moraxella catarrhalis immunoglobulin D-binding protein MID has conserved sequences and is regulated by a mechanism corresponding to phase variation.

Authors:  Andrea Möllenkvist; Therése Nordström; Christer Halldén; Jens Jørgen Christensen; Arne Forsgren; Kristian Riesbeck
Journal:  J Bacteriol       Date:  2003-04       Impact factor: 3.490

8.  Neisseria adhesin A variation and revised nomenclature scheme.

Authors:  Stefania Bambini; Matteo De Chiara; Alessandro Muzzi; Marirosa Mora; Jay Lucidarme; Carina Brehony; Ray Borrow; Vega Masignani; Maurizio Comanducci; Martin C J Maiden; Rino Rappuoli; Mariagrazia Pizza; Keith A Jolley
Journal:  Clin Vaccine Immunol       Date:  2014-05-07

Review 9.  A Moraxella catarrhalis vaccine to protect against otitis media and exacerbations of COPD: An update on current progress and challenges.

Authors:  Antonia C Perez; Timothy F Murphy
Journal:  Hum Vaccin Immunother       Date:  2017-10-03       Impact factor: 3.452

10.  The rise and spread of a new pathogen: seroresistant Moraxella catarrhalis.

Authors:  Thierry Wirth; Giovanna Morelli; Barica Kusecek; Alex van Belkum; Cindy van der Schee; Axel Meyer; Mark Achtman
Journal:  Genome Res       Date:  2007-09-25       Impact factor: 9.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.